The Medtronic pulsed field ablation (PFA) technology sets a new standard in safety and creates a paradigm shift in PFA electrophysiology. Tailor your ablations with the most versatile1 PFA system and tools, including single-shot and dual-energy wide area focal catheters. These PFA catheters are backed by over 15 years of research in irreversible electroporation (IRE).
Over 15 years of robust preclinical research in IRE and clinical application of pulsed field cardiac ablation yielded the PulseSelect™ pulsed field ablation system, the first PFA system approved for both paroxysmal and persistent AF, and the Affera™ mapping and ablation system integrated with the only all-in-one dual energy Sphere-9™ PFA catheter. The Medtronic PFA suite launches a new era in safety and and exciting shift in precision and efficiency in AFib treatment.
Wide area focal PFA catheters provide the ability to tailor lesion sets across the anatomy, ensuring consistent and reliable isolation.2
An all-in-one PFA solution to map, ablate, and validate, the Sphere-9™ catheter is the only wide area focal dual-energy pulsed field/radiofrequency catheter, exclusively integrated with the Affera™ mapping and ablation system.
RCT IDE comparing Affera™ mapping and ablation system with Sphere-9™ catheter to CARTO®* navigation and mapping system with THERMOCOOL SMARTTOUCH®* SF (STSF) catheter
420 patients | drug-refractory persistent AF | 23 centers | 40+ operators
Single-shot PFA catheters allow you to achieve wide area circumferential lesions designed with pulmonary vein isolation (PVI) in mind.
The PulseSelect™ PFA system features a single-shot over-the-wire PFA catheter, enabling mapping and precise lesion delivery with the freedom to adapt to your preferred workflow.
IDE evaluating the safety and effectiveness of the PulseSelect™ PFA system.
300 patients | drug-refractory PAF and PsAF patients | 41 centers | 67 operators
0.7%
Freedom from AF/AT/AFL
Began electroporation research for cardiac surgery in 2006
Affera™ Inc. established
Medtronic partners with world-leading experts in electroporation
The Sphere-9™ mapping and ablation catheter provides mapping and dual-energy ablation options including radiofrequency (RF) and pulsed field (PF) energies.
The PulseSelect™ pulsed field ablation (PFA) system enables both mapping and precise lesion delivery using biphasic waveform optimization.
The Nitron CryoConsole™ cardiac cryoablation system houses electrical and mechanical components as well as software used for cryotherapy procedures.
The Freezor™ cardiac cryoablation catheters are single-use catheters designed to ablate cardiac tissue by creating focal lesions.
The FlexCath Cross™ transseptal solution pairs with commercially available sheaths for both mechanical and radiofrequency (RF) crossing.
The FlexCath Contour™ steerable sheath provides enhanced maneuverability during atrial fibrillation ablation procedures.
The DiamondTemp™ ablation catheter is an open-irrigated radiofrequency (RF) ablation catheter used for cardiac ablation to treat atrial fibrillation.
The Arctic Front Advance™ over-the-wire balloon catheter is designed to enable pulmonary vein isolation (PVI) during atrial fibrillation ablation procedures.
The Arctic Front Advance Pro™ enables pulmonary vein isolation (PVI) using an anatomical approach during atrial fibrillation (AF) catheter ablation procedures.
The Achieve™ mapping catheter enables the assessment of pulmonary vein isolation during cryoablation procedures.
TM* and ®* Third-party brands are trademarks of their respective owners.
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.